Safety and Efficacy of Sirolimus-Eluting Stent in Patients With Acute Coronary Syndrome Undergoing Emergency Procedure

Abstract

Background Sirolimus-eluting stents (SES) reduce restenosis and revascularization rates, compared with baremetal stents (BMS), in elective percutaneous coronary intervention (PCI). This study investigated the safety and efficacy of SES for emergency PCI in acute coronary syndrome (ACS) patients. Methods and ResultsThe 154 consecutive patients (SES: n=77, BMS: n=77) admitted to hospital with ACS were enrolled in this study. Procedural success (%DS <50%, Thrombolysis In Myocardial Infarction grade 3), major adverse cardiac events (MACE) at 30 days and 8 months, and the incidence of stent thrombosis were evaluated. There was no difference between the groups regarding procedural success. Patients treated with SES had smaller stent diameter (SES 3.04 mm vs BMS 3.24 mm; p=0.01) and longer stent length (25.7 mm vs 21.2 mm; p=0.01). At 30 days, there was no difference between the groups in the incidence of cardiovascular events. At 8 months, patients treated with the SES had a lower rate of repeat PCI (5.6% vs 18.6%; p=0.04) and MACE (9.7% vs 27.1%; p=0.01). Stent thrombosis was no different between groups (1.4% vs 2.9%). Conclusion In emergency PCI for ACS patients, SES implantation significantly reduced cardiovascular events, compared with BMS, by decreasing the incidence of repeat PCI. The safety profile of SES is equal to that of BMS. (Circ J 2008; 72: 1054 -1058

Comparison of image characteristics of plaques in culprit coronary arteries by 64 slice CT and intravascular ultrasound in acute coronary syndromes

“…Therefore it would be very important to dissolve thrombi located in culprit lesions before implantation of coronary stents. These new stents have the potential to be used widely in treatment of ACS subjects from now on, and this new strategy would facilitate novel trends in coronary intervention for ACS subjects [20]. …”

Protection of mitochondrial genome integrity: A new stem cell property?

“…There is a high incidence of adverse cardiovascular events after percutaneous coronary intervention (PCI) in spite of improvements in intervention therapy [1]. Myocardial necrosis, assessed by cardiac biomarker elevation, is relatively frequent after PCI.…”

Diagnostic Value of Adenosine-Induced Left Ventricular Diastolic Dysfunction for Detecting Coronary Artery Restenosis in Patients Undergoing Stent Implantation by Stress ECG-Gated Myocardial Perfusion SPECT - A Pilot Study -

“…1 According to a previous report, implantation of a drug-eluting stent is well known to cause a low rate of coronary restenosis (approximately 8%) following PCIs. 2 However, detection of coronary restenosis after stent implantation is a still critical issue.…”